OVID · IV Rank History

Ovid Therapeutics Inc. Common Stock

IV rank shows where OVID's implied volatility sits within its own recent range: 0 is the lowest reading in the window, 100 the highest. This page gives the 52-week version, the 90-session version our screeners use, the IV percentile, and the daily history.

OVID's 30-day at-the-money implied volatility was 160.5% as of Oct 30, 2026. Its 52-week IV rank is 18 and its IV percentile is 55%: IV was lower on 55% of the past year's sessions. Over those 52 weeks it ranged from 59.7% (Sep 15, 2026) to 628.9% (Feb 13, 2026). On the 90-session window our screeners use, the IV rank is 43.

OVID IV rank history

367 sessions

Filled line: 90-session IV rank (0–100, left axis). Dashed line: 30-day at-the-money implied volatility (right axis).

OVID IV rank and implied volatility as of 2026-10-30

52-Week IV Rank
18
0 = year low, 100 = year high
IV Percentile
55%
of past-year sessions had lower IV
90-Session IV Rank
43
used by our screeners
30-Day ATM IV
160.5%
1-year average 175.1%
7-Day ATM IV
176.4%
90-session rank 12
52-Week IV High
628.9%
2026-02-13
52-Week IV Low
59.7%
2026-09-15
History Since
2023-05-15
367 sessions

How these are measured. Implied volatility here is OVID's 30-day at-the-money IV: the implied volatility of the calls and puts struck nearest the share price, blended between the expirations on either side of 30 days so every reading covers the same horizon. It's the IV level options traders usually quote, and it doesn't jump when the nearest expiration rolls from a weekly to a monthly. The 7-day figure is the same measure a week out, so it reacts first to near-term events such as earnings.

52-week IV rank = (today's IV − 52-week low) ÷ (52-week high − 52-week low) × 100. IV percentile is the share of the past year's sessions that closed with lower IV than today. The 90-session IV rank applies the same rank formula to the last 90 sessions, so it reacts faster.

A high reading means OVID options are expensive relative to their own recent history, which is common ahead of earnings or after a sharp move. It says nothing about which way the stock will go. The Vol Arb Screener ranks every tracked symbol by these measures.

OVID implied volatility by month

MonthAvg ATM IVHighLowAvg IV Rank (90-session)
Oct 2026 (to date) 137.1% 169.0% 102.1% 33
Sep 2026 101.0% 158.6% 59.7% 16
Aug 2026 109.7% 126.4% 78.2% 16
Jul 2026 137.9% 296.8% 98.8% 13
Jun 2026 150.7% 203.3% 102.2% 14
May 2026 126.6% 150.2% 83.7% 10
Apr 2026 122.7% 169.1% 74.1% 8
Mar 2026 150.8% 263.1% 87.4% 12
Feb 2026 259.9% 628.9% 165.1% 40
Jan 2026 213.9% 371.0% 132.1% 33
Dec 2025 190.6% 285.9% 83.2% 31
Nov 2025 196.8% 428.3% 117.8% 36
Oct 2025 160.0% 330.7% 84.5% 28
Sep 2025 314.0% 475.7% 177.3% 64
Aug 2025 305.2% 456.6% 199.2% 84
Jun 2024 166.4% 192.8% 115.0% 62
May 2024 137.0% 184.5% 96.1% 45
Apr 2024 125.3% 195.6% 39.9% 34
Mar 2024 103.3% 182.1% 57.5% 21
Feb 2024 119.9% 225.9% 65.0% 28
Jan 2024 76.0% 104.3% 52.6% 10
Dec 2023 110.8% 159.2% 82.8% 24
Nov 2023 91.6% 154.3% 58.0% 16
Oct 2023 98.0% 255.9% 66.5% 19
Sep 2023 109.6% 193.4% 58.5% 23
Aug 2023 92.6% 170.2% 62.0% 21
Jul 2023 113.4% 305.2% 57.3% —
Jun 2023 89.4% 179.5% 57.4% —
May 2023 80.8% 118.8% 49.7% —

OVID IV rank: last 30 sessions

DateIV Rank (90-session)30-Day ATM IV7-Day ATM IV
2026-10-30 43 160.5% 176.4%
2026-10-29 29 128.3% —
2026-10-28 37 146.8% —
2026-10-27 34 140.2% —
2026-10-26 33 137.9% —
2026-10-23 42 159.7% —
2026-10-22 40 153.3% —
2026-10-21 46 169.0% —
2026-10-20 36 145.0% —
2026-10-19 34 140.8% —
2026-10-16 41 157.2% —
2026-10-15 32 135.1% —
2026-10-14 29 127.7% 264.3%
2026-10-13 32 134.4% —
2026-10-12 26 120.8% —
2026-10-09 18 102.1% 88.9%
2026-10-08 26 121.2% 121.2%
2026-10-07 21 108.6% 179.0%
2026-10-06 24 116.1% 81.2%
2026-10-05 41 157.1% —
2026-10-01 24 116.3% 120.1%
2026-09-29 21 109.5% —
2026-09-28 40 153.5% —
2026-09-24 21 109.5% —
2026-09-22 22 112.9% —
2026-09-21 27 123.4% —
2026-09-18 2 63.2% —
2026-09-17 5 70.7% —
2026-09-16 17 100.3% —
2026-09-15 0 59.7% —

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.